ALCL is a distinct subtype of T cell NHL, first recognised by Stein et al. (1985) and later classified by the WHO as a CD30-positive T cell neoplasm characterised by large anaplastic lymphoid cells with pleomorphic nuclei and strong CD30 (Ki-1) expression [2]. Here, TNFRSF8 is linked to anaplastic large cell lymphoma.